Connecting the Oncology Community in Oklahoma

OSCO serves as the hub for oncology-related news and advances in Oklahoma. Our organization is made up of clinics and healthcare professionals working together to safeguard the rights of patients and to maintain high medical and ethical standards in the industry.

News

Enhertu approved in the US as first tumour-agnostic HER2-directed therapy for pr

Based on three Phase II trials of AstraZeneca and Daiichi Sankyo’s Enhertu which showed clinically meaningful responses across a broad range of tumours Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of […]

Read More...

AstraZeneca announces results of TOPAZ-1 Phase III Trial

Imfinzi plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial Longest survival follow-up ever reported for immunotherapy treatment in this setting  Updated exploratory results from the TOPAZ-1 Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care chemotherapy demonstrated a clinically meaningful long-term overall […]

Read More...

Did you miss OSCO’s Presentation of the Best of SABCS® or need to claim conti

OSCO’s recent presentation of the Official Review of the San Antonio Breast Cancer Symposium provided attendees with excellent updates on many breast cancer topics.  The first session was presented by Joyce O’Shaughnessy, MD on HR+ Breast Cancer.  The second session was a Radiation Oncology Update presented by Danushka Seneviratne, MD, PhD.  After a short break […]

Read More...

Upcoming Events

Join the Oklahoma Society of Clinical Oncology, Inc. for our Spring meeting on April 6, 2024, the Best of SABCS, an officially licensed program of the San Antonio Breast Cancer Symposium.    This meeting will break down the most clinically relevant abstracts from SABCS’s annual symposium, allowing attendees to engage with the latest strategies in oncology education.  Details of the in-person meeting are:

Learn More »

Become a Sponsor

Your company can sponsor OSCO and the work we do by becoming a corporate member today! For more information or to sign up, contact Kathy Musson, OSCO Executive Director at kmussonokc@gmail.com or by phone at 405-850-8334.

See More »

Who We Are

Who We Are

The Oklahoma Society of Clinical Oncology (OSCO) is Oklahoma’s only professional organization that represents all those in oncology. Our membership works to advance the sciences of hematology and oncology and its sub-specialties, and to improve services to the public by studying the socio-economic aspects of the practice of our members.

Learn More »